Gilead, Regeneron, Amgen: Covid Treatment Stocks Still Worth Looking At As Vaccine Nears?Forbes • 10/02/20
Gilead Sciences Update on Supply and Distribution of Veklury® (remdesivir) in the United StatesBusiness Wire • 10/01/20
Gilead Sciences Presents Data From HIV Research and Development Programs at HIV Glasgow 2020Business Wire • 09/30/20
The Zacks Analyst Blog Highlights: Anheuser-Busch InBev, Gilead Sciences, Canadian National Railway, Stryker Corp and Goldman SachsZacks Investment Research • 09/28/20
European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid ArthritisBusiness Wire • 09/25/20